Pancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment Amy G. Egan, M.D., M.P.H., Eberhard Blind, M.D., Ph.D., Kristina Dunder, M.D., Pieter A. de Graeff, M.D., B. Timothy Hummer, Ph.D., Todd Bourcier, Ph.D., and Curtis Rosebraugh, M.D., M.P.H. N Engl J Med 2014; 370:794-797February 27, 2014DOI: 10.1056/NEJMp1314078
MDedge, Off-Label Liraglutide in Type 1 Diabetes, In a small pilot study, off-label liraglutide as adjunctive therapy in adults with type 1 diabetes on insulin reduced glycemic oscillations and lowered hemoglobin A1c levels, explains Dr. Paresh Dandona.
